Literature DB >> 20481574

Accuracy assessment of protein-based docking programs against RNA targets.

Yaozong Li1, Jie Shen, Xianqiang Sun, Weihua Li, Guixia Liu, Yun Tang.   

Abstract

Ribonucleic acid (RNA) molecules play central roles in a variety of biological processes and, hence, are attractive targets for therapeutic intervention. In recent years, molecular docking techniques have become one of the most popular and successful approaches in drug discovery; however, almost all docking programs are protein based. The adaptability of popular docking programs in RNA world has not been systematically evaluated. This paper describes the comprehensive evaluation of two widely used protein-based docking programs--GOLD and Glide--for their docking and virtual screening accuracies against RNA targets. Using multiple docking strategies, both GOLD 4.0 and Glide 5.0 successfully reproduced most binding modes of the 60 tested RNA complexes. Applying different docking/scoring combinations, significant enrichments from the simulated virtual and fragment screening experiments were achieved against tRNA decoding A site of 16S rRNA (rRNA A-site). Our study demonstrated that current protein-based docking programs can fulfill general docking tasks against RNA, and these programs are very helpful in RNA-based drug discovery and design.

Mesh:

Substances:

Year:  2010        PMID: 20481574     DOI: 10.1021/ci9004157

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  17 in total

1.  Nucleotide docking: prediction of reactant state complexes for ribonuclease enzymes.

Authors:  Brigitta Elsässer; Gregor Fels
Journal:  J Mol Model       Date:  2010-12-01       Impact factor: 1.810

2.  Structure-based ensemble-QSAR model: a novel approach to the study of the EGFR tyrosine kinase and its inhibitors.

Authors:  Xian-qiang Sun; Lei Chen; Yao-zong Li; Wei-hua Li; Gui-xia Liu; Yao-quan Tu; Yun Tang
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

Review 3.  Small molecule compounds targeting miRNAs for cancer therapy.

Authors:  Paloma Del C Monroig; Lu Chen; Shuxing Zhang; George A Calin
Journal:  Adv Drug Deliv Rev       Date:  2014-09-17       Impact factor: 15.470

Review 4.  Methods to enable the design of bioactive small molecules targeting RNA.

Authors:  Matthew D Disney; Ilyas Yildirim; Jessica L Childs-Disney
Journal:  Org Biomol Chem       Date:  2014-02-21       Impact factor: 3.876

5.  Synthesis, antibacterial studies, and molecular modeling studies of 3,4-dihydropyrimidinone compounds.

Authors:  Vanitha Ramachandran; Karthiga Arumugasamy; Sanjeev Kumar Singh; Naushad Edayadulla; Penugonda Ramesh; Sathish-Kumar Kamaraj
Journal:  J Chem Biol       Date:  2015-07-04

6.  Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin.

Authors:  Sichuan Xu; Shaoming Chi; Yi Jin; Qiang Shi; Maofa Ge; Shu Wang; Xingkang Zhang
Journal:  J Mol Model       Date:  2011-05-03       Impact factor: 1.810

7.  Amikacin Inhibits miR-497 Maturation and Exerts Post-ischemic Neuroprotection.

Authors:  S Sinoy; S M Fayaz; K D Charles; V K Suvanish; Josef P Kapfhammer; G K Rajanikant
Journal:  Mol Neurobiol       Date:  2016-05-21       Impact factor: 5.590

Review 8.  Computational approaches to predicting the impact of novel bases on RNA structure and stability.

Authors:  Jason G Harrison; Yvonne B Zheng; Peter A Beal; Dean J Tantillo
Journal:  ACS Chem Biol       Date:  2013-10-08       Impact factor: 5.100

9.  Novel insights of structure-based modeling for RNA-targeted drug discovery.

Authors:  Lu Chen; George A Calin; Shuxing Zhang
Journal:  J Chem Inf Model       Date:  2012-09-21       Impact factor: 4.956

10.  Novel ligands for a purine riboswitch discovered by RNA-ligand docking.

Authors:  Peter Daldrop; Francis E Reyes; David A Robinson; Colin M Hammond; David M Lilley; Robert T Batey; Ruth Brenk
Journal:  Chem Biol       Date:  2011-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.